| III-42 Pascal Chanu Pediatric plans optimization of C.E.R.A. (Continuous Erythropoietin Receptor Activator): clinical evidence obtained through a model-based integration of multisource data Thursday 09:55-11:30 |
| III-42 Pascal Chanu Pediatric plans optimization of C.E.R.A. (Continuous Erythropoietin Receptor Activator): clinical evidence obtained through a model-based integration of multisource data Thursday 09:55-11:30 |